期刊論文| 1. | Herrine, S. K.(2002)。Approach to the patient with chronic hepatitis C virus infection。Annals of Internal Medicine，136(10)，747-757。   |
| 2. | Flamm, S. L.(2003)。Chronic hepatitis C virus infection。JAMA，289(18)，2413-2417。 |
| 3. | Lam, Nancy P.、Hepatitis, C.(1999)。Natural History, Diagnosis, and Management。American Journal of Health-System Pharmacy，56(10)，961-973。 |
| 4. | Seeff, Leonard B.、Hoofnagle, Jay H.(2002)。National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C: 2002-June 10。Hepatology，36(5)Suppl 1，3-15。 |
| 5. | Gow, Paul J.、Mutimer, David(2001)。Treatment of Chronic Hepatitis。BMJ，23(17)，1164-167。 |
| 6. | Satoor, Sumalatha、Raufman, Jean- Pierre(2001)。Treatment of hepatitis C.。Clinical Cornerstone，3(6)，37-46。 |
| 7. | Mehta, Shruti H.、Strathdee, Steffanie A.(2001)。Association between Hepatitis C Virus Infection and Diabetes Mellitus。Epidemiologic Reviews，23(2)，302-312。 |
| 8. | Bacon, Bruce R.(2002)。Treatment of Patients with Hepatitis C and Normal Serum Aminotransferase Levels。Hepatology，36，179-184。 |
| 9. | Keeffe, Emmet B.(2002)。Current Treatment of Chronic Hepatitis。C. Medscape Gastroenterology Journal，4(2)。 |
| 10. | Di Bisceglie, Adrian M.、Hoofnagle, Jay H.(2002)。Optimal Therapy of Hepatitis C。Hepatology，36(5)，121-279。 |
| 11. | Perry, Caroline M.、Jarvis, Blair(2001)。Peginterferon-a-2a(40KD)- A Review of its use in the Management of Chronic Hepatitis C。Drugs，61(15)，2263-2288。 |
| 12. | Jacobs, R. Jake、Raymond, S.、Koff, Allen S.(2002)。Meyerhoff. The Cosst-Effectiveness of Vaccinating Chronic Hepatitis C Patients A。The American Journal of Gastroenterology，97(2)，427-434。 |
| 13. | Koff, Raymond S.(2001)。Risks Associated with Hepatitis A and Hepatitis B in Patient with Hapatiti。Journal of clinical gastroenterology，33(1)，26。 |
| 14. | Koff, Raymond S.(2002)。Combination Hepatitis Vaccines for Immunoprophylaxis An Update。Digestive Disease and Sciences，47(6)，20-26。 |
| 15. | Thomas, David L.(2002)。Hepatitis C and Human Immunodeficiency virus Infection。Hepatology，36，201-209。 |
| 16. | Bruno, Raffaele(2002)。Massimo Puoti, Paolo Soriano, Gaetano Filice. HCV Chronic Hapatitis in Patients with HIV. Clinical Management Issues。The American Journal Gastroenterology，97(7)，1598-1606。 |
| 17. | Buti, Maria、Sanchez-Avila, Francisco、Lurie, Yoav、Auristela, Stalgis Valdes、Martell, Maria、Esteban, Rafael(2002)。Viral Kinetics in Genotype 1 Chronic Hepatitis C Patients during Therapy with 2 Different Dose of Peginterferon alfa-2b plus Ribavirin。Hapatology，35(4)，930-937。 |
| 18. | Christensson, B. S.、Me Hutchinson, J. G.、Mieli-Vergani, G.、Sterling, R.(2002)。Interferon- a -2b Plus Rbavirin。Drugs，62(3)，507-556。 |
| 19. | Lan, Johnson Y. N.、Tam, Robert C.、Liang, T. Jake、Hong, Zhi(2002)。Mechanism of action of ribavirin in the combination treatment of chronic HCV infection。Hepatology，35(5)，1002-1009。 |
| 20. | Keating,Gillian M.、Curran, Monique P.(2003)。Peginterferon- [alfa]-2a(40KD) Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C。Drugs，63(7)，701-730。 |
| 21. | Bruchfeld, Annette、Lindahl, Karin、Schvarcz, Robert、Stahle, Lars(2002)。Dosage of Ribavirin in Patients with Hapatitis C should Be Based on Renal function: A Population Pharmacokinetic Analysis。Therapeutic Drug Monitoring，24(6)，701-708。 |
| 22. | Fried, Michael W.(2002)。Side Effects of Hepatitis C and Their Management。Hepatology，36(5)Suppl，237-244。 |
| 23. | Kumar, K. Shiva、Russo, Mark W.、Borczuk, Alain C.、Melissa, Brown、Stephen, P.(2002)。Therapy for Hepatitis C。The American Journal of Gastroenterology，97(9)，2432-2440。 |
| 24. | Castera, Laurent、Buffet, Catherine、Zigante, Franck、Hardy, Patrick(2002)。Incidence of Interferon Alfa-Induced Depression in Patients with Chronic Hepatitis C。Hepatology，35(4)，978-979。 |
| 25. | Schulman, Sam(2002)。Inhibition of Warfarin Activity by Ribavirin。The Annals of Pharmacotherapy，36，72-74。 |
| 26. | Becqument, Laurent、Chazouilleres, Olivier、Serfaty, Lawrence、Poirier, Jean Marie、Broly, Franck(2002)。Effect of Interferon a -Ribavirin biotherapy on cytochrome P450 1A2 and 2D6 and N-acetyltranferase-2 activities in Patient with chronic active hepatitis C。Clinical pharmacology and therapeutics，171(6)，488-495。 |
| 27. | Dettmer, Robert M.、Reinus, John F.、Ciain, David J.、Isaacson, Mary P.、Sarabanchong, Viyada Garcia(2002)。Interferon-a-2b and Ribavirin for Retreatment of Chronic Hapatitis C。Hepato-Gastroenterolog，49(45)，758-763。 |
| 28. | Wasa, Motoh I.、Kaiko, Masahiko、Iroma, Jiro、Kobayashi, Yoshinao、Tanaka, Yuji、Higuchi, Kunihiro(2002)。Dietary Iron Restriction Improves Aminotransferase Levels in Chronic Hepatitis。Hepato-Gastroenterology，49(44)，529-531。 |
| 29. | Griffiths, Adrian、Olynyk, John K.(2002)。Iron and Response to Treatment of Hepatitis C。The American Journal of Gastroenterology，97(4)，788-790。 |
| 30. | Schedlofsky, Steven I.(2002)。Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?。The American Journal of Gastroenterology，97(5)，1093-1096。 |
| 31. | Strader, Doris B.、Bacon, Bruce R.、Lindsay, Karen L.、La Brecque, Douglas R.、Morgan, Timothy、Wright, E. C.(2002)。Use of Complementary and Alternative Medicine in Patients with Liver Disease。The American Journal of Gastroenterlogy，97(9)，2391-2397。 |
| 32. | Wang, Dennis V. C. A.、Fugh-Berman, Adriane(2002)。Herbal interactions with cardiovascular drug。The Journal of Cardiovascular Nursing，16(4)，64-70。 |
| 33. | Fugh-Berman, Adriane(2000)。Herb-Drug interaction。The Lancet Ltd，355，134-138。 |
| 34. | Wang, Zaiqi、Hamman, Mitchell A.、Huang, Shiew-Mei、Lesko, Lawrence J.(2002)。ect of St John's Wort on the Pharmacokinetics of Fexofenadine。Clinical Pharmacology & Therapeutics，71(6)，414-420。 |
| 35. | Ernst, Edzard(2002)。The Risk- Benefit Profike of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava。Annals of Internal Medicine，136(1)，42-53。 |
| 36. | 鄭振鴻、吳正文、任珮鸞、呂萬安(20020600)。加味逍遙散治療慢性肝炎之研究。中醫藥雜誌，13(2)，67-73。 延伸查詢 |
| 37. | 李欣南、廖亞雯、潘志泉(20030900)。憂鬱症及其藥物治療。臺灣醫界，46(9)，35-38。 延伸查詢 |
| 38. | Yamauchi, K.、Akbar, S. M. F.、Horike, N.、Michitaka, N.、Onji, M.(2002)。Increased Serum Level of Macrophage Inflammatory Protein-3a in Chronic Viral Hepatitis: Prognostic importance of Macrophage Inflammatory Protein-3a During Interferon Therapy in Chronic Hapatitis C。Journal of Viral Hepatitis，9(3)，213-220。 |